TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models

Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions

Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity

Major HBV splice variant encoding a novel protein important for infection

Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects

Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels

Swine pseudorabies virus attenuated vaccine reprograms the kidney cancer tumor microenvironment and synergizes with PD-1 blockade

Light-Induced Mechanically Robust Hydrogel with Superelasticity and Fatigue Resistance for Bioprinting of Cell-Laden Architectures

A Dual-domain Engineered Antibody for Efficient HBV Suppression and Immune Responses Restoration

Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness

Micronanoparticled risedronate exhibits potent vaccine adjuvant effects